On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products...more
1/16/2025
/ Artificial Intelligence ,
Clinical Trials ,
Compliance ,
Digital Health ,
Draft Guidance ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Machine Learning ,
Patents ,
Pharmaceutical Industry ,
Popular ,
Regulatory Requirements ,
Risk Management ,
Trade Secrets
Nikhil Pradhan (Senior Counsel, Boston) recently joined Zebec Networks’ Future of Money podcast to explore the intersection of artificial intelligence and the blockchain ecosystem with Parth Shah. The below episode transcript...more
Health care merger and acquisition (M&A) activity reached a significant level in 2022, even if not matching 2021’s record-breaking standard. This reflects the overall economy’s holding pattern in which resources are still...more
Artificial intelligence has weaved its way into almost every industry, from detecting cancer to predicting employee performance to teaching robots and vehicles to use all kinds of sensor data to make human-like decisions in...more
2/20/2020
/ Artificial Intelligence ,
Business Development ,
Emerging Technology Companies ,
Intellectual Property Protection ,
Investment Management ,
Investors ,
IP License ,
IP Portfolio ,
Patent Applications ,
Patent Portfolios ,
Patents ,
Popular ,
Startups ,
Venture Capital